Basics Replimune Group, Inc. IPO Date: July 16, 2018 Sector: Healthcare Industry: Biotech Market Cap: $649.07M Activated in VL: True Average Daily Range Avg Daily Range: $0.58 | 3.17% Avg Daily Range (30 D): $0.40 | 4.68% Avg Daily Range (90 D): $0.37 | 3.63% Institutional Daily Volume Avg Daily Volume: .36M Avg Daily Volume (30 D): 1.12M Avg Daily Volume (90 D): .78M Trade Size Avg Trade Size (Sh.): 76 Avg Trade Size (Sh.) (30 D): 78 Avg Trade Size (Sh.) (90 D): 71 Institutional Trades Total Inst.Trades: 1,982 Avg Inst. Trade: $1.8M Avg Inst. Trade (30 D): $1.46M Avg Inst. Trade (90 D): $1.43M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.78M Avg Closing Trade (30 D): $1.06M Avg Closing Trade (90 D): $1.32M Avg Closing Volume: 110.07K         News May 13, 2025 @ 5:00 PM Metastatic Colorectal Cancer Clinical Trial Pipeli... Source: Delveinsight Nov 26, 2024 @ 4:55 AM Replimune Announces Pricing of Upsized Public Offe... Source: Globe Newswire Oct 23, 2024 @ 5:00 PM Non-melanoma Skin Cancer is Predicted to Exhibit R... Source: Delveinsight Oct 9, 2024 @ 8:01 PM Replimune Announces Inducement Grants Under Nasdaq... Source: N/A Sep 15, 2024 @ 1:45 PM Replimune Presents Primary Analysis Data from IGNY... Source: Replimune Group, Inc. Financials   TTM Q4 2025 FY 2025 Basic EPS $-3.07 $-.82 $-3.07 Diluted EPS $-3.07 $-.82 $-3.07 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -247.3M $ -74.13M $ -247.3M Operating Income / Loss $ -261.63M $ -79.33M $ -261.63M Cost of Revenue $ $ $ Net Cash Flow $ 36.67M $ -61.12M $ 36.67M PE Ratio     Splits Dec 01, 2010:   15:1